WeedLife News Network
Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife Social Network.
The U.K. Anti-Doping organization is changing its rules, reports Canex. Athletes who fail drug tests for cannabis and cocaine use will face shorter bans as the organization looks to place a greater focus on performance-enhancing drugs. The reform is part of a wider movement focused on athlete welfare, and the acceptance of widening cannabis use. Ad
Updated regulations around access to medical marijuana caregivers emerged last week as a point of contention among some in the cannabis community, with a patient advocacy group and individual patients disagreeing over the right approach. During a public hearing on Aug. 3, officials from the Massachusetts Patient Advocacy Alliance opposed the Cannab
Colorado’s hemp industry is undergoing a market correction, with decreased production following an oversupply in recent years, The Grand Junction Daily Sentinel reports. “There’s hundreds of thousands if not millions of pounds of hemp flower that has not sold from last year. We created a huge, huge oversupply and you’ll have that in agriculture,” W
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) reported first-quarter fiscal 2021 net revenue increased 22% to $110 million. Original link
For years, cannabis stocks were the greatest thing since sliced bread on Wall Street. The expectation of ongoing state-level legalization in the U.S., coupled with Canada becoming the first industrialized country in the modern era to give marijuana the green light, was forecast to send pot stock valuations into the heavens -- and for a period of ti
As the number of licensed medical cannabis patients passed 8% of Oklahoma’s population, the Oklahoma Tax Commission reported taxes levied on sales in July exceeded $12 million. State Question 788, approved by 57% of those who voted in the June 2018 election, included provisions for a 7% tax on medical cannabis sales. The Oklahoma Tax Commission int
The adult-use cannabis market in Illinois is booming. Illinois has sold about $300 million worth of cannabis products since the adult-use market opened in January. The state hit record-breaking sales once again in July and is expected to continue on an upwards curve as the market grows and stabilizes. A lot of Illinois’ sales can be attributed to
Legal marijuana products contain extraordinary levels of THC, which could cause dependence and mental health issues with habitual use. The marijuana you see in stores today isn’t like what the hippies rolled in the 70s. If you follow cannabis news, you have likely heard some version of that sentiment by a public health official. Last year, U.S. Sur
A review of published literature has found that chronic pain patients who use cannabis in addition to pharmaceutical medications showed a reduction in their use of opioids and required fewer visits to the emergency room. The study, “Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: A systematic review,
So long as it is extremely difficult and expensive to start and run a licensed cannabis business, there will be people who opt for the illicit market. It seems like every week, there’s a new announcement of state or local enforcement actions or raids of allegedly unlicensed cannabis operators in California. Some time ago, this would have been welco
Penn State College of Medicine researchers have found products containing cannabinoids may have impacts on the effects of some conventional prescription drugs. The researchers have put together a list of 57 medications that may not function as intended when used with cannabis products including medical cannabinoids, CBD oil and medical or recreatio
Late Friday, Maricopa County Superior Court Judge James Smith ruled that the Smart and Safe Act ballot initiative to legalize recreational marijuana for adults 21 and older in Arizona did not mislead voters about key provisions in its 100-word summary, as a frivolous lawsuit by a local anti-marijuana group claimed. Overcoming the lawsuit and gettin
Thailand’s ailing economy, particularly its tourism and agriculture sectors, is poised to get a boost from new rules that ease the private cultivation and sale of medical marijuana. The Cabinet amended the Narcotics Act on Aug. 4, pending Parliament’s approval, to allow private medical operators -- a category including some traditional medicine pra
The industry doesn't have the political clout or voter passion behind them to push weed over the finish line, but you can help. Despite evidence that two-thirds of Americans support legalizing cannabis, federal moves towards legalization have been small and halting. Even simple measures, such as regulating banking in states where cannabis is legal,
But first, we need to do these 5 things. Billions of dollars are sitting at the doorstep of Capitol Hill, begging to participate in the economy. But with some wise moves by the Federal government and regulatory agencies, cannabis-generated revenue could be a significant answer to our financial crisis stemming from the pandemic. For proof, look at
Some doctors in Western Australian and their patients should have easier and faster access to medical cannabis resulting from a deal signed between Jupiter Health Clinics and Montu. Founded in 2011, Jupiter Health and Medical Services is a network of more than 300 doctors in 30 medical practices across the state, and is one of the largest networks
CBD could prove to be an effective treatment for people suffering from marijuana use disorder, the results of a new study published this week have shown. Inspired by a “substantial and unmet clinical need” for the treatment of cannabis use disorders, researchers from the University of Bath in the UK conducted a double-blind randomized controlled t
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) stock fell over 13% to lately trade at $6.03 after the company reported a net loss for the second quarter of $107 million versus last year’s earnings of $185 million for the same time period. The loss of $0.31 cents per share was worse than the FactSet estimate for a loss of $0.07 per share. Original lin